Back to Newsroom

Sigilon Therapeutics to Host Interactive Webinar “Beyond Gene Therapies: The Next Wave of Protein-Generating Therapeutics” on Dec. 4, 2017

CAMBRIDGE, Mass., Nov. 30, 2017 – Sigilon Therapeutics, a biopharmaceutical company that discovers and develops immune-privileged living therapeutic implants, today announced that it will host a live, online educational webinar “Beyond Gene Therapies: The Next Wave of Protein-Generating Therapeutics” on Monday, Dec. 4, 2017, at 10 a.m. EST. Following presentations by Daniel Anderson, Ph.D., and Robert Langer, Sc.D., of the Sigilon scientific advisory board, journalist Luke Timmerman will moderate a discussion of questions submitted by audience participants on current methods and promising new protein delivery technologies.
READ MORE…